Is hyperparathyroidism in Indians a different phenotype compared to the Western world
Not Applicable
Completed
- Conditions
- Health Condition 1: E213- Hyperparathyroidism, unspecified
- Registration Number
- CTRI/2022/04/041684
- Lead Sponsor
- Amrita Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 346
Inclusion Criteria
Patients with surgically proven primary hyperparathyroism were included in our study
Exclusion Criteria
Patients suspected to have manifestations of multiple endocrine neoplasia were excluded.
Patients operated for secondary or tertiary HPT were also excluded
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Demographic profile, primary symptom, age at the onset of primary symptom, co-morbid diseases, number of parathyroid lesions, histological features of parathyroid lesions <br/ ><br>1. Persistent normocalcaemia <br/ ><br> <br/ ><br>2. Recurrent Hypercalcemia <br/ ><br> <br/ ><br>3. Persistent HypercalcemiaTimepoint: Symptoms of patient in Pre op presentation in months and years <br/ ><br>Post op period in days with <br/ ><br>1. Persistent normocalcaemia <br/ ><br> <br/ ><br>2. Recurrent Hypercalcemia <br/ ><br> <br/ ><br>3. Persistent Hypercalcemia
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil